180 related articles for article (PubMed ID: 4577114)
1. Prevention of intraventricular haemorrhage in babies receiving artificial ventilation.
Thomas DB; Burnard ED
Med J Aust; 1973 May; 1(19):933-6. PubMed ID: 4577114
[No Abstract] [Full Text] [Related]
2. Intraventricular haemorrhage in the newborn.
Gupta JM; Starr H; Fincher P; Lam-Po-Tang PR
Med J Aust; 1976 Aug; 2(9):338-40. PubMed ID: 995015
[TBL] [Abstract][Full Text] [Related]
3. Intracranial haemorrhage in low-birth-weight infants and prophylactic administration of coagulation-factor concentrate.
Waltl H; Födisch HJ; Kurz R; Hohenauer L; Mitterstieler G; Rössler H
Lancet; 1973 Jun; 1(7815):1284-6. PubMed ID: 4126076
[No Abstract] [Full Text] [Related]
4. Human prothrombin complex.
N Engl J Med; 1965 Sep; 273(13):715-6. PubMed ID: 5827038
[No Abstract] [Full Text] [Related]
5. [Terminalis hemorrhage in low birth-weight infants: ineffectiveness of treatment with coagulation factors. (a controlled study) (author's transl)].
Waltl H; Födisch H; Kurz R; Hohenauer L; Mitterstieler G; Rössler H
Monatsschr Kinderheilkd (1902); 1974 May; 122(5):192-7. PubMed ID: 4605985
[No Abstract] [Full Text] [Related]
6. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
O'Leary DS; Ruymann FB; Conrad ME
J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
[No Abstract] [Full Text] [Related]
7. Activated prothrombin concentrate for patients with factor VIII inhibitors.
Kurczynski EM; Penner JA
N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
[No Abstract] [Full Text] [Related]
8. Editorial: Factor VIII inhibitors.
Deykin D
N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
[No Abstract] [Full Text] [Related]
9. [Clinical experience with the PPSB fraction in surgery].
Frick U
Zentralbl Chir; 1972 Feb; 97(5):150-3. PubMed ID: 5020589
[No Abstract] [Full Text] [Related]
10. [6-years' experience with the clinical use of the hemostatic preparation, PPSB].
Koniukhov SG; Saltykova ZA; Tarasova LN
Probl Gematol Pereliv Krovi; 1977 Aug; 22(8):37-40. PubMed ID: 928338
[No Abstract] [Full Text] [Related]
11. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
Quinlan DJ; Eikelboom JW; Weitz JI
Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012
[No Abstract] [Full Text] [Related]
12. [Administration of a new prothrombin complex concentrate in patients treated with anticoagulants and in patients with liver diseases].
Fischer M; Falkensammer C; Gauss P; Korp W; Kubiena K; Neubert J; Schnack H; Weissmann A
Med Welt; 1973 Nov; 24(48):1899-902. PubMed ID: 4774863
[No Abstract] [Full Text] [Related]
13. ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal.
Lang E
Ann Intern Med; 2014 Apr; 160(8):JC6. PubMed ID: 24733223
[No Abstract] [Full Text] [Related]
14. [On the problem of enteral resorption of coagulation factors in early infancy].
Göltner E; Ströder J
Wien Klin Wochenschr; 1966 Oct; 78(41):695-7. PubMed ID: 5929473
[No Abstract] [Full Text] [Related]
15. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders].
Fischer M
Wien Klin Wochenschr; 1983 Feb; 95(3):82-5. PubMed ID: 6858171
[TBL] [Abstract][Full Text] [Related]
16. Beriplex--the new generation haemorrhage stopper.
Nandanan S; Goel R
J Obstet Gynaecol; 2010; 30(8):872-3. PubMed ID: 21126138
[No Abstract] [Full Text] [Related]
17. [On the therapy of bleeding tendency due to vitamin K deficiency and dysfunction of the liver during the first year of life. (Combined treatment with a concentrate of factors II, VII, IX and X and heparin) (author's transl)].
Göbel U; Petrich C
Monatsschr Kinderheilkd (1902); 1974 Feb; 122(2):60-4. PubMed ID: 4594807
[No Abstract] [Full Text] [Related]
18. Clinical use of human prothrombin complexes.
Tullis JL; Melin M; Jurigian P
N Engl J Med; 1965 Sep; 273(13):667-74. PubMed ID: 5827030
[No Abstract] [Full Text] [Related]
19. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
Liu J; Wang Q; Gao F; He JW; Zhao JH
J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625
[TBL] [Abstract][Full Text] [Related]
20. The preparation for therapeutic use of a concentrate of factor IX containing also factors II, VII and X.
Bidwell E; Booth JM; Dike GW; Denson KW
Br J Haematol; 1967 Jul; 13(4):568-79. PubMed ID: 6029956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
